Mai Ashizawa

567 citations
22 papers · 431 indexed · h-index 11
Topics
Genetic factors in colorectal cancer (5 papers)Cancer Immunotherapy and Biomarkers (5 papers)Immune cells in cancer (4 papers)
Partner nations
Japan

In The Last Decade

Mai Ashizawa

21 papers receiving 426 citations

Peers

Mai Ashizawa
Comparison fields: 5 of 47
  • Molecular Biology 222
  • Oncology 206
  • Immunology 114
  • Cancer Research 96
  • Pathology and Forensic Medicine 87
Replace Valeria Pusceddu with:
Valeria Pusceddu Italy
Xiangyan Jiang China
Aung Kyi Thar Min Japan
Armin Pauer Germany
De Sen Wan China
Albin Rudisch Austria
Qinbo Cai China
Zhifei Zu United States
Heather A. Hirsch United States
Ritika Kundra United States
Mai Ashizawa relative to Valeria Pusceddu Italy Valeria Pusceddu's profile →
Citations per field
00.5×3.5×
Valeria Pusceddu · 1×
Citations per year

Countries citing papers authored by Mai Ashizawa

Since Specialization
Citations

This map shows the geographic impact of Mai Ashizawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mai Ashizawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mai Ashizawa more than expected).

Fields of papers citing papers by Mai Ashizawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mai Ashizawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mai Ashizawa. The network helps show where Mai Ashizawa may publish in the future.

Co-authorship network of co-authors of Mai Ashizawa

This figure shows the co-authorship network connecting the top 25 collaborators of Mai Ashizawa. A scholar is included among the top collaborators of Mai Ashizawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mai Ashizawa. Mai Ashizawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2
[The Evaluation of Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer].
0
3 1
4 3
5 29
6 92
7 31
8 2
9 24
10 40
11 32
12 3
13 2
14 1
15 37
16 4
17
[Regulation of PD-L1 by MicroRNA in Mismatch Repair Deficient-Colorectal Cancer].
4
18 13
19 43
20 9

About Mai Ashizawa

Mai Ashizawa is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology, having authored 22 papers that have together received 431 indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immune cells in cancer (4 papers). The work is most often cited by research in Oncology (206 citations), Cancer Research (96 citations) and Immunology (114 citations). Mai Ashizawa has collaborated with scholars based in Japan. Frequent co-authors include Hirokazu Okayama, Koji Kono, Shinji Ohki, Wataru Sakamoto, Tomoyuki Momma, Motonobu Saito, Aung Kyi Thar Min, Shotaro Fujita, Hisahito Endo and Daisuke Ujiie. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026